Short Communication on the Inflammation of respiratory diseases

Sharma kumar D^*
*Correspondence: Sharma kumar D, Department of Tuberculosis & Respiratory Diseases, India, Email:

Respiratory presentations

The population of 47 LDCs accounted for 12% of the world's total population, but their total GDP accounted for only 2% of the world.These countries are not only suffering from infectious diseases such as COVID-19, tuberculosis, and AIDS, but are also facing the risk of food shortages and humanitarian crises.. Present study was done in an urban locality of Ghaziabad inhabited mainly by low socio – economic status population and Given the possible harm from inhaled nitric oxide and the absence of a clear mortality benefit, recently published guidelines on the management of critically ill adults with Coronavirus Disease 2019 issued a strong recommendation against the routine use of nitric oxide in patients with ARDS. However, the guidelines recommend a trial of inhaled nitric oxide as a "rescue" therapy, after trying other options, in view of the finding of improved oxygenation. The guidelines further caution that if inhaled nitric oxide is used without a good response in terms of oxygenation, it should be tapered off to avoid rebound pulmonary vasoconstriction that can occur with prolonged use and abrupt discontinuation.While the activation of blood coagulation is essential in counteracting viral infections along with the immune system trapping viruses by forming a fibrin network, a massive inflammatory and coagulative response is dangerous because it can lead to a local thrombosis in the lungs. Furthermore, this severe acute inflammation induces a local consumption coagulopathy, i.e. Disseminated Intravascular